Physician profile
Ellen Lamb
NPI 1487915039
$2,186.86
in general payments reported to CMS, 2019-2025
22 companies · $499 in 2025
The $499 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.36 · 2020: $99.95 · 2021: $102 · 2022: $601 · 2023: $431 · 2024: $439 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.39 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.58 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $220.63 | 2022-2025 | |
| Millicent US INC | $198.34 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Astellas Pharma US INC | $184.45 | 2023-2025 | Veozah |
| Pfizer INC. | $177.89 | 2021-2024 | |
| Agile Therapeutics, INC. | $159.43 | 2021-2024 | Twirla |
| Exact Sciences Corporation | $159.30 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $157.28 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $89.61 | 2019-2021 | |
| Minerva Surgical, INC | $86.84 | 2022 | |
| Evofem Biosciences, INC. | $85.46 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.53 | 2022-2023 | |
| Exeltis, USA INC. | $63.15 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $61.88 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $44.86 | 2024-2025 | Paragard T 380a |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $27.53 | 2025 | Quikclot |
| Convatec INC. | $25.90 | 2025 | |
| Shield Therapeutics INC | $19.77 | 2024 | |
| Therapeuticsmd, INC. | $18.33 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.03 | 2020 | |
| Channel Medsystems, INC. | $13.81 | 2023 | |
| Myovant Sciences INC. | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.